Saturday, 5 September 2026European Markets

AVANTIUM Stock Was 14.54% Up Today

Loading stream...

(VIANEWS) - The Market ended the session with AVANTIUM (AVTX.AS) rising 14.54% to €2.56 on Wednesday, following the last session's downward trend. AEX-Index rose 0.6% to €915.68, following the last session's downward trend on what was a somewhat up trend exchanging session today.

AVANTIUM's last close was €2.24, 42.5% under its 52-week high of €3.89.

About AVANTIUM

Avantium N.V., a chemical technology company, develops and commercializes renewable chemistry solutions in the Netherlands. The company operates through three segments: Avantium R&D Solutions, Avantium Renewable Chemistries, and Avantium Renewable Polymers. It offers furandicarboxylic acid, a building block for polyethylene furanoate (PEF); and PEF, a plant-based recyclable plastic for use as packaging material. The company also provides catalyst testing systems, including Flowrence that provides catalyst testing and adsorbents. In addition, it offers R&D system and refinery catalyst testing services. Further, the company develops ray technology to produce mono-ethylene glycol from industrial sugars; and dawn technology which converts non-food plant-based feedstock to industrial sugars and lignin. Additionally, it produces polyesters using plantMEG. The company was founded in 2000 and is headquartered in Amsterdam, the Netherlands.

Earnings Per Share

As for profitability, AVANTIUM has a trailing twelve months EPS of €-0.47.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -36.88%.

Volatility

AVANTIUM's last week, last month's, and last quarter's current intraday variation average was 5.95%, 1.46%, and 2.78%.

AVANTIUM's highest amplitude of average volatility was 5.95% (last week), 3.04% (last month), and 2.78% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 23.4%, now sitting on 21.4M for the twelve trailing months.

Volume

Today's last reported volume for AVANTIUM is 1948800 which is 476.88% above its average volume of 337817.

More news about AVANTIUM (AVTX.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com